{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:41Z","timestamp":1786988141750,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejphar.2026.178681","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:39:34Z","timestamp":1771918774000},"page":"178681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Metformin plus naringin: a new optional treatment for metabolic dysfunction associated with fatty liver disease in a rat experimental model of high-fructose consumption"],"prefix":"10.1016","volume":"1019","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0281-0404","authenticated-orcid":false,"given":"Mar\u00eda A.","family":"Rizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda V.","family":"Scalerandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nori","family":"Tolosa de Talamoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5061-978X","authenticated-orcid":false,"given":"Valeria A.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178681_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1432-1033.1974.tb03751.x","article-title":"Heterogeneity of erythrocyte catalase II: isolation and characterization of normal and variant erythrocyte catalase and their subunits","volume":"48","author":"Aebi","year":"1974","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejphar.2026.178681_bib2","article-title":"Dietary fructose: a literature review of current evidence and implications on metabolic health","volume":"16","author":"Agarwal","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2026.178681_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0076-6879(85)13073-9","article-title":"Determination of glutathione and glutathione disulfide in biological samples","volume":"113","author":"Anderson","year":"1985","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejphar.2026.178681_bib4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.fct.2014.04.032","article-title":"Camel's milk ameliorates TNBS-induced colitis in rats via downregulation of inflammatory cytokines and oxidative stress","volume":"69","author":"Arab","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2026.178681_bib5","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cgh.2019.12.026","article-title":"Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study","volume":"18","author":"Baratta","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178681_bib6","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","article-title":"Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation","volume":"73","author":"Bates","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178681_bib7","doi-asserted-by":"crossref","first-page":"C873","DOI":"10.1152\/ajpcell.00604.2020","article-title":"The intersection of metformin and inflammation","volume":"320","author":"Bharath","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2026.178681_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112319","article-title":"Malonylation of acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD","volume":"42","author":"Cao","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2026.178681_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/kjm2.12395","article-title":"Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: a community-based cross-sectional study","volume":"37","author":"Chen","year":"2021","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.ejphar.2026.178681_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100511","article-title":"Comprehensive analysis of liver macrophage composition by flow cytometry and immunofluorescence in murine NASH","volume":"2","author":"Daemen","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.ejphar.2026.178681_bib11","first-page":"505","article-title":"Expression of fatty acid synthase in nonalcoholic fatty liver disease","volume":"3","author":"Dorn","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2026.178681_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178681_bib13","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.3390\/molecules28155645","article-title":"Molecular mechanism pathways of natural compounds for the treatment of non-alcoholic fatty liver disease","volume":"28","author":"Fang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.178681_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tox.2011.03.009","article-title":"Pre-cancerous changes in urothelial endocytic vesicle leakage, fatty acid composition, and as and associated element concentrations after arsenic exposure","volume":"284","author":"Grasso","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2026.178681_bib15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/00365520902845268","article-title":"Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial","volume":"44","author":"Haukeland","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2026.178681_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-lancet liver commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2026.178681_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/10815589221141830","article-title":"Serum liver enzymes and metabolic syndrome from the rafsanjan cohort study","volume":"71","author":"Khalili","year":"2023","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.ejphar.2026.178681_bib18","first-page":"351","article-title":"Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease","volume":"20","author":"Kohjima","year":"2007","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2026.178681_bib19","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.3390\/ijms23084305","article-title":"\u03d2-targeted therapies in the treatment of non-alcoholic fatty liver disease in diabetic patients","volume":"23","author":"Lange","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178681_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/br.2012.18","article-title":"Metformin in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"1","author":"Li","year":"2013","journal-title":"Biomed Rep"},{"key":"10.1016\/j.ejphar.2026.178681_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1364881","article-title":"Research advances in the therapy of metabolic syndrome","volume":"15","author":"Lin","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178681_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7138194","article-title":"Exploration of the protective mechanism of naringin in the acetaminophen-induced hepatic injury by metabolomics","volume":"2022","author":"Lin","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2026.178681_bib23","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3390\/biom13081199","article-title":"Combination of pioglitazone and metformin actions on liver lipid metabolism in obese mice","volume":"13","author":"Liu","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2026.178681_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real time quantitative PCR and the 2-DDCT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ejphar.2026.178681_bib25","article-title":"Protective effect of isoorientin on oleic acid-induced oxidative damage and steatosis in rat liver cells","volume":"13","author":"Luo","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178681_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/niox.2000.0319","article-title":"A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite","volume":"5","author":"Miranda","year":"2001","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejphar.2026.178681_bib27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1872-034X.2008.00464.x","article-title":"Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease","volume":"39","author":"Mitsuyoshi","year":"2009","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.ejphar.2026.178681_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2026.178681_bib29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbacli.2015.02.001","article-title":"Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy","volume":"3","author":"Nagaya","year":"2015","journal-title":"BBA Clin."},{"key":"10.1016\/j.ejphar.2026.178681_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.70549","article-title":"Lycopene alleviates lipid dysregulation, oxidative stress, and hypercholesterolemia in obese rats subjected to a high-fat diet","volume":"13","author":"Noreen","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.ejphar.2026.178681_bib31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2026.178681_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4254\/wjh.v6.i4.199","article-title":"Insulin sensitizers for the treatment of non-alcoholic fatty liver disease","volume":"6","author":"Ozturk","year":"2014","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178681_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1049818","article-title":"Naringin attenuates fructose-induced NAFLD progression in rats through reducing endogenous triglyceride synthesis and activating the Nrf2\/HO-1 pathway","volume":"13","author":"Pengnet","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178681_bib34","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3390\/nu16132121","article-title":"Long-term impact of nutritional intervention with increased polyphenol intake and physical activity promotion on oxidative and inflammatory profiles in patients with metabolic syndrome","volume":"16","author":"Quetglas-Llabr\u00e9s","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2026.178681_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front. Biosci. (Landmark Ed)."},{"key":"10.1016\/j.ejphar.2026.178681_bib36","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/antiox10050674","article-title":"Analysis and optimization of conditions for the use of 20,70-Dichlorofluorescein diacetate in cultured hepatocytes","volume":"10","author":"Reiniers","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2026.178681_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1139\/apnm-2021-0473","article-title":"Naringin prevents bone damage in the experimental metabolic syndrome induced by a fructose-rich diet","volume":"47","author":"Rivoira","year":"2022","journal-title":"Appl. Physiol. Nutr. Metabol."},{"key":"10.1016\/j.ejphar.2026.178681_bib38","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.2174\/0929867327666200604171351","article-title":"New perspectives in the pharmacological potential of naringin in medicine","volume":"28","author":"Rivoira","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178681_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biopha.2018.05.120","article-title":"Naringin attenuates liver damage in streptozotocin-induced diabetic rats","volume":"105","author":"Rodr\u00edguez","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.178681_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2017.11.002","article-title":"Naringin prevents the inhibition of intestinal Ca2+ absorption induced by a fructose rich diet","volume":"636","author":"Rodr\u00edguez","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2026.178681_bib41","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s40200-021-00916-x","article-title":"The effects of high fructose fruits and honey on the serum level of metabolic factors and nonalcoholic fatty liver disease","volume":"20","author":"Sadeghi","year":"2021","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.ejphar.2026.178681_bib42","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2026.178681_bib43","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.178681_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2024.100737","article-title":"Biomarkers of hepatic toxicity: an overview","volume":"100","author":"Thakur","year":"2024","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.ejphar.2026.178681_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1287916","article-title":"Association between nonalcoholic fatty liver disease and increased glucose-to-albumin ratio in adults without diabetes","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.178681_bib47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2147\/JHC.S450423","article-title":"Lipid metabolism as a potential target of liver cancer","volume":"11","author":"Wu","year":"2024","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.ejphar.2026.178681_bib48","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0002-9378(79)90708-7","article-title":"Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood","volume":"135","author":"Yoshioka","year":"1979","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2026.178681_bib49","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.metabol.2010.10.003","article-title":"Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis","volume":"60","author":"Zhu","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2026.178681_bib50","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1038\/s41598-022-09610-1","article-title":"Metformin ameliorates hepatic steatosis induced by olanzapine through inhibiting LXR\u03b1\/PCSK9 pathway","volume":"12","author":"Zhu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178681_bib51","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.2147\/DDDT.S307257","article-title":"Metformin in combination with malvidin prevents progression of non-alcoholic fatty liver disease via improving lipid and glucose metabolisms, and inhibiting inflammation in type 2 diabetes rats","volume":"15","author":"Zou","year":"2021","journal-title":"Drug Des. Dev. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926001639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926001639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:46:54Z","timestamp":1779425214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926001639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":50,"alternative-id":["S0014299926001639"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178681","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin plus naringin: a new optional treatment for metabolic dysfunction associated with fatty liver disease in a rat experimental model of high-fructose consumption","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178681"}}